- -------------------------------------------------------------------------------
- -------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest
event reported):
September 10, 1998
PACIFIC PHARMACEUTICALS, INC.
-------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware
-------------------------------------------------------
(State or other jurisdiction of incorporation)
1-9613 36-3258753
- ------------------------ -------------------------------------
(Commission File Number) (IRS Employer Identification Number)
6730 Mesa Ridge Rd.
Suite A
San Diego, California 92121
------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (619) 550-3900
--------------
Item 5. Other Events.
On September 10, 1998, Pacific Pharmaceuticals, Inc. (the "Company") received
notice from the American Stock Exchange ("AMEX") that the Executive Committee
of the Exchange's Board of Governors has denied the Company's appeal of the
determination by the Exchange to remove the Company's Common Stock from the
AMEX because the Company no longer satisfies all of the financial guidelines
of the AMEX for continued listing. The last day of trading of the Company's
Common Stock on AMEX will be September 18, 1998. The Company anticipates that
trading will commence September 21, 1998 on the Over the Counter Bulletin
Board under the ticker symbol PPHA.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) EXHIBITS. The following exhibit accompanies this Report:
Exhibit
Number Exhibit Description
------- -------------------
99.62 News release dated September 11, 1998 announcing that
the Company has received notice from the AMEX that the
Executive Committee of the Exchange's Board of
Governors has denied the Company's appeal of the
determination by the Exchange to remove the Company's
Common Stock from the AMEX.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
PACIFIC PHARMACEUTICALS, INC.
By: /s/ James Hertzog
-------------------------
James Hertzog
Date: September 15, 1998 Controller-Principal Accounting Officer
3
Index to Exhibits
-----------------
Exhibit Sequentially
Number Description of Exhibit Numbered Page
------- ---------------------- -------------
99.62 News release dated September 11, 1998
announcing that the Company has received
notice from the AMEX that the Executive
Committee of the Exchange's Board of Governors
has denied the Company's appeal of the
determination by the Exchange to remove the
Company's Common Stock from the AMEX.
4